Fulgent Genetics Inc (FLGT)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1,219,960 | 1,235,330 | 1,386,050 | 1,278,720 | 700,461 |
| Total stockholders’ equity | US$ in thousands | 1,133,230 | 1,136,100 | 1,269,880 | 1,165,880 | 569,387 |
| Financial leverage ratio | 1.08 | 1.09 | 1.09 | 1.10 | 1.23 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,219,960K ÷ $1,133,230K
= 1.08
The financial leverage ratio of Fulgent Genetics Inc has shown a decreasing trend over the last few years. It decreased from 1.23 at the end of December 31, 2020, to 1.08 at the end of December 31, 2024. This indicates that the company has been gradually reducing its reliance on debt to finance its operations and investments, which could be a positive sign for investors and creditors. A lower financial leverage ratio suggests a smaller proportion of debt in the company's capital structure relative to equity, potentially reducing the company's financial risk and increasing its financial stability.
Peer comparison
Dec 31, 2024